Objective: Hypoalbuminemia in acute stroke patients is associated with increased mortality and morbidity. The aim of our study was to determine the frequency and correlates of hypoalbuminemia in unselected cohort of patients with acute cerebral infarction. Design: Prospective study. Setting: University hospital. Subjects: Seven hundred and five consecutive ischemic stroke patients. Methods: Albumin and other serum protein fractions were measured within 36 h after stroke using electrophoresis. Results: Hypoalbuminemia defined as serum albumin level o35 g/l was found in 45.5% of patients. Serum albumin level correlates significantly with age (r ¼ À0.13, Po0.01), Scandinavian Stroke Scale score (r ¼ 0.14, Po0.01), body temperature on admission (r ¼ 0.14, Po0.01), leukocyte count (r ¼ À0.17, Po0.01), fasting glucose (r ¼ À0.16, Po0.01), total cholesterol (r ¼ 0.14, Po0.01), a1-globulin (r ¼ À0.48, Po0.01), a2-globulin (r ¼ À0.49, Po0.01), b-globulin (r ¼ À0.26, Po0.01) and g-globulin (r ¼ À0.35, Po0.01). Conclusions: Hypoalbuminemia is a frequent finding in acute stroke patients and it is associated with more severe stroke and pro-inflammatory pattern of serum protein electrophoresis.
Introduction
Low serum albumin level is frequently found in hospitalized older persons. Hypoalbuminemia was reported in up to 19% of stroke patients (Davalos et al., 1996; Gariballa et al., 1998; Davis et al., 2004) . Stroke patients with hypoalbuminemia at admission had increased risk of infective complications (Gariballa et al., 1998; Dziedzic et al., 2006) , death (Gariballa et al., 1998; Davis et al., 2004) and poor functional outcome (Davalos et al., 1996; Gariballa et al., 1998) .
The goal of our study was to determine the frequency and correlates of hypoalbuminemia in unselected cohort of acute stroke patients.
Materials and methods
This study was a part of the prospective study investigating the influence of serum albumin on stroke outcome (Dziedzic et al., 2004) . All patients admitted between June 2000 and April 2003 with a diagnosis of ischemic stroke were eligible for this study, regardless of age, stroke etiology and concomitant diseases. The inclusion criteria were (1) firstever stroke and (2) admission delay of less than 24 h from onset of symptoms. Patients with transient ischemic attack were excluded from the study.
Arterial hypertension was diagnosed when its presence was documented in medical records or when at least two readings of blood pressure were X140 mm Hg (systolic) or X90 mm Hg (diastolic) after the acute phase of stroke. Ischemic heart disease was diagnosed when there was a history of angina pectoris or myocardial infarction. Diabetes mellitus was diagnosed if its presence was documented in medical records or patient was taking insulin or an oral hypoglycemic agents or patients fulfilled the WHO criteria for diabetes 2 weeks after stroke onset (Alberti and Zimmet, 1998) . A patient was defined as a smoker if there was a history of cigarette smoking during the last 5 years.
All patients underwent head computed tomography (CT) scan within 24 h after stroke onset.
Stroke severity on admission was assessed using Scandinavian Stroke Scale (SSS) (Scandinavian Stroke Study Group, 1985) . Severe stroke was defined as SSS score p25.
Total serum protein, fasting glucose and cholesterol were measured within 36 h after stroke onset. Total serum protein level was determined using Hitachi analyzer, and serum protein fractions (albumin, a-, b-, g-globulin) were measured using electrophoresis (Beckman Instruments, Fullerton, USA). Total cholesterol, high-density lipoprotein (HDL), cholesterol and triglycerides were determined by enzymatic method (Boeringher Mannheim) using analyzer RA-1000. Low-density lipoprotein (LDL) cholesterol was calculated by the Friedewald formula. Fasting glucose was measured by automated chemistry analyzer (Hitachi 917, Basel, Switzerland).
The study protocol was approved by the local Bioethics Committee and informed consent was obtained from all patients.
The w 2 -test was used to compare proportions and MannWhitney's test to compare continuous variables between groups. Spearman rank correlation test was used for correlation analysis. Values of less than 0.05 were considerate to indicate statistical significance. To determine the relationship between hypoalbuminemia and stroke severity we used logistic regression analysis.
Results
Seven hundred and five patients (age range 19-99 years) with first-ever ischemic stroke admitted to our stroke unit within 24 h after stroke onset were included. They were recruited from 979 patients with ischemic stroke hospitalized in our stroke unit in the study period. Hypoalbuminemia defined as serum albumin level o35 g/l was found in 321 from 705 patients (45.5%). One hundred and sixty-seven patients had serum albumin level o30 g/l (23.7%).
The characteristics of patients with hypoalbuminemia and those with normoalbuminemia are shown in Table 1 .
The patients with hypoalbuminemia were older and less frequently smoker when compared with patients with normoalbuminemia. The patients with hypoalbuminemia had significantly higher fasting glucose, leukocyte count, a-, b-, g-globulin level and body temperature on admission and lower total cholesterol and LDL-cholesterol level. The patients with hypoalbuminemia had more severe neurological deficit on admission measured in SSS than normoalbuminemic subjects.
Serum albumin level correlates significantly with age (r ¼ À0.13, Po0.01), SSS score (r ¼ 0.14, Po0.01) (Figure 1 ), body temperature on admission (r ¼ À0.14, Po0.01), leukocyte count (r ¼ À0.17, Po0.01), fasting glucose (r ¼ À0.16, Po0.01), total cholesterol (r ¼ 0.14, Po0.01), LDL-cholesterol (r ¼ 0.12, Po0.01), HDL-cholesterol (r ¼ 0.09, Po0.01), a1-globulin (r ¼ À0.48, Po0.01), a2-globulin (r ¼ À0.49, Po0.01), b-globulin (r ¼ À0.26, Po0.01) and g-globulin (r ¼ À0.35, Po0.01).
On univariate analysis, age was associated with increased risk of hypoalbuminemia (odds ratio (OR To determine if hypoalbuminemia independently predicts stroke severity we created logistic regression model with dichotomised SSS score (p25) as dependent variable and with hypoalbuminemia (serum albumin o35 g/l), age (continuous variable), atrial fibrillation and triglyceride (continuous variable) as independent variables. Triglyceride and atrial fibrillation were put into the model, because we previously demonstrated that these factors could influence stroke severity (Dziedzic et al., 2004a) . Triglyceride level does not change significantly during stroke (Yan et al., 2005) . Therefore, triglyceride concentration measured in acute stroke are likely to reflect pre-stroke value. Hypoalbuminemia (OR: 1.73, 95% CI: 1.23-2.43), age (OR: 1.03, 95% CI: 1.02-1.05) and triglyceride (OR: 0.68, 95% CI: 0.53-0.88), but not atrial fibrillation (OR: 1.41, 95% CI: 0.95-2.09) were independently associated with severe stroke.
Discussion
We found high frequency of hypoalbuminemia in unselected cohort of acute stroke patients. Previous studies reported significantly lower frequency of hypoalbuminemia in stroke patients. Davalos et al. (1996) assessed malnutrition in 104 patients with acute ischemic and hemorrhagic stroke. Serum albumin level was measured within 24 h after stroke onset, and hypoalbuminemia (serum albumin level o35 g/l) was observed in 7.7% of patients. Gariballa et al. (1998) found serum albumin concentration o35 g/l in 19% from 201 ischemic stroke patients. In that study, serum albumin level was measured within 48 h after stroke onset. In both the above-mentioned studies, patients with some concomitant disorders (e.g. liver disease, renal failure, malignancy, etc.) were excluded from the study. Davis et al. (2004) measured serum albumin concentration in 185 patients with cerebral infarction and intracerebral hemorrhage within 24 h after stroke onset. They found hypoalbuminemia (serum albumin level p34 g/l) in 16.2% of patients. The frequency of hypoalbuminemia in our study is also higher than previously reported in patients admitted to Polish hospitals (20.7%) (Dzieniszewski et al., 2005) . The difference in frequency of hypoalbuminemia between our study and previous reports could be to partially caused by patients selection (ischemic and hemorrhagic stroke vs only ischemic stroke; selected versus unselected cohort of patients), methods and timing of assessments; however, it does not explain several-fold higher frequency of hypoalbuminemia in Polish patients.
Hypoalbuminemia in acute stroke patients could be a result of malnutrition and/or underlying disease processes such as renal or hepatic insufficiency, uncontrolled heart failure, malignancy, etc. Protein energy malnutrition affects 8-30% of stroke patients on admission (Cairella et al., 2004) , and low serum albumin at admission is significantly associated with premorbid nutrition (Davis et al., 2004) . 
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The high frequency of low serum albumin level among our stroke patients could be caused by malnutrition. Although our study was not design to investigate nutritional status of stroke patients, the lower total cholesterol level in hypoalbuminemic patients compared with normoalbuminemic subjects suggests malnutrition in the former. Additional studies are needed to determine the etiology of hypoalbuminemia in Polish stroke patients.
A few epidemiological studies suggest that low serum albumin level could be associated with increased risk of stroke. In one prospective study group with high serum albumin (444 g/l) vs low serum albumin (o42 g/l) had reduced stroke incidence (Gillum et al., 1994) . In the crosssectional Norwegian Oslo Health Study, low albumin (p47 g/l) was associated with increased prevalence of selfreported stroke (OR: 1.83; 95% CI: 1.20-2.78) after adjusting for age and sex (Hostmark and Tomten, 2006) .
It is proposed that chronic inflammation is common to the pathogenesis of malnutrition and vascular disease (Kaysen, 2006) . Increased level of C-reactive protein (CRP) is independent risk factor for stroke (Rost et al., 2001; Cao et al., 2003) . Systemic inflammation causes a fall of albumin concentration by reducing synthesis of proteins and increasing their catabolic state (Ballmer, 2001 ). In our study, hypoalbuminemia was accompanied by increased level of a-, b-, g-globulin, the pattern typical for inflammation. We speculate that pre-stroke hypoalbuminemia could be related to chronic inflammatory process, which causes an increase of positive acute-phase protein including CRP, which belongs to globulin fraction and a decrease of serum albumin as negative acute phase protein.
We found negative correlation between serum albumin level and degree of neurological deficit and between albumin and body temperature and glucose level, factors which could influence stroke outcome (Reith et al., 1996; Weir et al., 1997) . Albumin level and stroke severity could be related to each other in two ways. On the one hand, hypoalbuminemia could predispose to more severe stroke. Experimental studies demonstrated neuroprotective properties of albumin in animal models of cerebral ischemia (Belayev et al., 2001 (Belayev et al., , 2002 . Proposed beneficial effects of higher serum albumin level include binding to free fatty acids, inhibition of oxygen radical production and support of endothelial function. Recent clinical study suggests that 25% human albumin in doses ranging up to 2.05 g/kg is well tolerated by patients with acute ischemic stroke and may have beneficial effect on stroke outcome Palesch et al., 2006) . Patients with low serum albumin could be a risk of severe stroke due to the insufficient neuroprotection mediated by albumins. On the other hand, acute-phase reaction in course of acute cerebral ischemia could cause a fall in albumin level, which is proportional to stroke severity.
The strengths of our study include the relatively large sample size of unselected patients. Study weakness includes delay between stroke onset and blood sampling. We measured serum albumin within 36 h after stroke onset. It could cause that serum albumin concentration might be influenced by acute-phase reaction. However, previous study (Acalovschi et al., 2003) showed that acute-phase reaction defined as CRP level is most pronounced until 3-7 days after stroke onset.
Conclusion
Results of our study suggest that hypoalbuminemia is a frequent finding in Polish patients with acute stroke and it is associated with more severe stroke and proinflammatory pattern of serum protein electrophoresis.
